Rituximab, Fludarabine and Alkylating Agents in Peripheral Neuropathies Related to IgM Monoclonal Gammopathy with Autoantibody Activity against Myelin-Associated-Glycoprotein : a Retrospective Study of 15 Patients.
Lionel Karlin(Hôpital Lyon Sud), Jean‐Claude Brouet(Centre National de la Recherche Scientifique), Bertrand Arnulf(Université Paris Cité), Claire Fieschi(Délégation Paris 7), Lionel Galicier(Hôpital de la Timone), Jean‐Paul Fermand(Sorbonne Université), Sophie Cereja(Hôpital Saint-Louis), Marion Malphettes(Hôpital Saint-Louis), Bouchra Asli(Hôpital Saint-Louis), Éric Oksenhendler(Université Paris Cité)
Cited by 1
Related Papers
Biologic and clinical significance of cryoglobulins
|The American Journal of Medicine|1974|1.7k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695